VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
LPCN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
LPCNLipocine Inc.
$2.12$12M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksLPCNQuarterly Financials

Lipocine Inc. (LPCN) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Lipocine Inc. (LPCN) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

LPCN Income Statement

Quarterly statement

LPCN Income Statement

Lipocine Inc. (LPCN) annual income statement — 15-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue190.1K119.4K1.15M114.57K622.85K93.86K3.49M089.56K7.62M216.19K-3.12M054.99K00500K016.09M54.99K
Revenue Growth %-69.48%27.2%-67.19%-595.42%-98.77%1514.99%100%-13751.93%---100%--100%-100%----
Cost of Goods Sold014.81K14.98K02.14M0001.87M0002.52M01.67M2.1M2.9M02.25M2.37M
COGS % of Revenue-12.41%1.31%-343.06%---2093.14%-------579.6%-14.01%4303.23%
Gross Profit190.1K104.58K1.13M114.57K-1.51M93.86K3.49M0-1.79M7.62M216.19K-3.12M-2.52M54.99K-1.67M-2.1M-2.4M013.83M-2.31M
Gross Margin %100%87.59%98.69%100%-243.06%100%100%--1993.14%100%100%100%-100%---479.6%-85.99%-4203.23%
Gross Profit Growth %112.56%11.42%-67.62%-15.19%-98.77%1514.99%100%29.03%13751.93%112.94%-48.64%-4.89%--112.08%9.13%-63.72%-657.77%7.09%
Operating Expenses3.03M3.95M3.65M3.48M890.43K2.18M1.95M2.63M1.51M4.39M2.81M3.92M1.44M4.39M890.34K798.94K1.13M3.13M1.05M1.22M
OpEx % of Revenue1595.14%3311.68%318.34%3033.51%142.96%2326.82%55.73%-1683.04%57.69%1299.58%-125.6%-7989.86%--225.9%-6.52%2222.33%
Selling, General & Admin990.96K1.2M983.39K767.84K890.43K1.12M873.05K1.05M1.51M1.58M1.13M1.04M1.44M1.29M890.34K798.94K1.13M1.24M1.05M1.22M
SG&A % of Revenue521.28%1008.79%85.86%670.17%142.96%1195.85%25.01%-1683.04%20.69%524.82%-33.39%-2340.99%--225.9%-6.52%2222.33%
Research & Development2.04M2.75M2.69M2.71M2.12M1.06M1.07M1.59M02.82M02.88M03.11M02.1M01.89M00
R&D % of Revenue1073.86%2302.89%235.2%2363.34%340.48%1130.97%30.73%--37.01%--92.21%-5648.86%------
Other Operating Expenses00-31.09K0-1000K000001000K0000-1000K0000
Operating Income-2.84M-3.85M-2.52M-3.36M-2.4M-2.09M1.55M-2.63M-3.29M3.22M-2.59M-7.04M-3.96M-4.34M-2.56M-2.9M-3.53M-3.13M12.78M-3.53M
Operating Margin %-1495.14%-3224.09%-219.65%-2933.51%-386.03%-2226.82%44.27%--3676.18%42.31%-1199.58%225.6%--7889.86%---705.51%-79.47%-6425.56%
Operating Income Growth %-18.21%-84.17%-262.78%-27.77%26.98%-164.86%159.59%62.65%16.76%174.28%-1.27%-142.93%-12.14%-38.54%-120.03%17.95%-17.97%-0.55%366.24%19.23%
EBITDA-2.83M-3.83M-2.5M-3.34M-2.39M-2.07M1.56M-2.62M-3.28M3.23M-2.59M-7.04M-3.95M-4.33M-2.56M-2.9M-3.52M-3.13M12.78M-3.04M
EBITDA Margin %-1487.43%-3211.68%-218.51%-2919.45%-383.44%-2210.23%44.71%--3666.67%42.42%-1195.88%225.36%--7881.09%---704.99%-79.48%-5521.44%
EBITDA Growth %-18.4%-84.84%-260.33%-27.57%27.28%-164.21%160.38%62.73%16.81%174.55%-1.06%-142.88%-11.99%-38.46%-120.01%4.6%47.79%5.12%366.31%30.58%
D&A (Non-Cash Add-back)14.65K14.81K13K16.11K16.11K15.57K15.57K8.51K8.51K8.51K8K7.75K8.09K4.82K2.58K2.58K2.58K1.72K3800
EBIT-2.62M-3.67M-2.37M-3.19M-2.21M-1.86M1.78M-2.22M-3.07M3.51M-2.28M-7.04M-3.96M-4.34M-2.23M-2.41M-2.62M-3.47M12.66M-3.04M
Net Interest Income219.85K177.57K145.72K174.21K198.64K225.51K233.12K273.57K308.85K331.36K299.38K317.57K379.52K370.47K297.16K163.97K62.31K22.05K-9.61K-27.57K
Interest Income219.85K177.57K145.72K174.21K198.64K225.51K233.12K273.57K308.85K331.36K299.38K317.57K379.52K370.47K297.16K163.97K69.88K22.05K22.44K17.26K
Interest Expense00000000000000007.57K032.05K44.84K
Other Income/Expense219.85K177.57K145.72K174.21K198.64K225.51K236.7K411.65K224.41K291.29K311.65K392.4K406.98K468.6K331.4K490.21K895.75K-355.94K-159.93K452.38K
Pretax Income-2.62M-3.67M-2.37M-3.19M-2.21M-1.86M1.78M-2.22M-3.07M3.51M-2.28M-6.65M-3.55M-3.87M-2.23M-2.41M-2.63M-3.49M12.62M-3.08M
Pretax Margin %-1379.49%-3075.37%-206.92%-2781.46%-354.13%-1986.57%51.04%--3425.62%46.13%-1055.42%213.04%--7037.7%---526.36%-78.48%-5602.97%
Income Tax200000020000481200555002004810020000
Effective Tax Rate %-0.01%0%0%0%0%-0.01%0%0%-0.02%0.01%-0.02%0%0%-0.01%-0.02%0%0%-0.01%0%0%
Net Income-2.62M-3.67M-2.37M-3.19M-2.21M-1.86M1.78M-2.22M-3.07M3.51M-2.28M-6.65M-3.55M-3.87M-2.23M-2.41M-2.63M-3.49M12.62M-3.08M
Net Margin %-1379.59%-3075.37%-206.92%-2781.46%-354.13%-1986.78%51.04%--3426.15%46.13%-1055.68%213.04%--7038.06%---526.36%-78.48%-5602.97%
Net Income Growth %-18.9%-96.9%-232.99%-43.63%28.12%-153.08%178.09%66.64%13.53%190.79%-2.35%-176.07%-34.84%-10.97%-117.66%21.81%61.35%-3.55%379.83%28.56%
Net Income (Continuing)-2.62M-3.67M-2.37M-3.19M-2.21M-1.86M1.78M-2.22M-3.07M3.51M-2.28M-6.65M-3.55M-3.87M-2.23M-2.41M-2.63M-3.49M12.62M-3.08M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.32-0.54-0.42-0.59-0.41-0.350.32-0.41-0.570.66-0.43-1.26-0.68-0.74-0.43-0.46-0.61-0.672.43-0.68
EPS Growth %21.95%-54.29%-231.25%-43.9%28.07%-153.03%174.42%67.46%16.18%189.19%0%-173.91%-11.48%-10.45%-117.7%32.35%54.48%4.29%311.3%42.86%
EPS (Basic)-0.32-0.54-0.42-0.59-0.41-0.350.33-0.41-0.570.66-0.43-1.27-0.68-0.76-0.43-0.52-0.50-0.672.43-0.59
Diluted Shares Outstanding8.22M6.79M5.71M5.41M5.35M5.35M5.42M5.35M5.34M5.36M5.32M5.29M5.23M5.23M5.23M5.25M5.26M5.19M5.23M5.23M
Basic Shares Outstanding8.22M6.79M5.45M5.41M5.35M5.35M5.34M5.35M5.34M5.32M5.29M5.23M5.19M5.11M5.16M4.62M4.31M5.19M5.19M4.53M
Dividend Payout Ratio--------------------